<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01093638</url>
  </required_header>
  <id_info>
    <org_study_id>CTILYAB004409LND10LaniadoH</org_study_id>
    <nct_id>NCT01093638</nct_id>
  </id_info>
  <brief_title>Oral Formulation of Insulin for Preterm Infants</brief_title>
  <official_title>A Multi-center, Randomized, Double-blinded Clinical Study to Assess the Effect of Insulin Enriched Formula on Gastrointestinal Tract Maturation in Pre-term Infants.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutrinia</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nutrinia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate the effect of oral formulation of insulin on preterm infants, born
      between 26-33 weeks of pregnancy, weighing over 750 grams, who meet the inclusion and
      exclusion criteria established in this protocol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will aim to determine whether an oral formulation of insulin administration
      enhances gastrointestinal maturation. The gastrointestinal maturation will be evaluated by
      the ability of premature infants to achieve complete enteral feeds. The insulin concentration
      administered in the study is physiological and within the insulin concentration range present
      in human breast milk and colostrum.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of days to achieve complete enteral feeding</measure>
    <time_frame>Up to 28 days or discharge and at 3 months of age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of gastric residual &gt; 2 ml/kg</measure>
    <time_frame>Up to 28 days or discharge, at 3 months of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of gastric residual &gt; 50% of previous feeding</measure>
    <time_frame>Up to 28 days or discharge and at 3 months of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days to discharge</measure>
    <time_frame>Up to 28 days or discharge and at 3 months of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight gain</measure>
    <time_frame>Up to 28 days or discharge and at 3 months of age</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Premature Birth of Newborn</condition>
  <arm_group>
    <arm_group_label>Oral Formulation of Insulin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral formulation of insulin fed concomitantly with premature infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Formulation of Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral formulation of placebo fed concomitantly with premature infant formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Oral Formulation of Insulin</intervention_name>
    <description>Oral formulation of insulin fed concomitantly with infant formula</description>
    <arm_group_label>Oral Formulation of Insulin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral formulation of placebo fed concomitantly with infant formula</description>
    <arm_group_label>Oral Formulation of Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Pre-term infants 26-33 weeks gestation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>26 Weeks</minimum_age>
    <maximum_age>33 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naim Shehadeh, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NICU, Laniado Hospital</name>
      <address>
        <city>Natanya</city>
        <zip>42150</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2010</study_first_submitted>
  <study_first_submitted_qc>March 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2010</study_first_posted>
  <last_update_submitted>August 9, 2016</last_update_submitted>
  <last_update_submitted_qc>August 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

